Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 7:10 AM UTC
| NCT Number | NCT06397911 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE2 |
| Target Enrollment | 114 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Oneness Biotech Co., Ltd. |
| Last Updated on CT.gov | June 15, 2026 (Jun 15, 2026) |
As of August 31, 2026: Clinical trial NCT06397911 is currently recruiting participants. This phase2 study for atopic dermatitis is actively seeking new participants at 6 locations across the United States. The study is sponsored by Oneness Biotech Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06397911 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06397911 was last updated Jun 15, 2026 (June 15, 2026). HelloStudys verifies this status automatically.